{"id":1390,"date":"2020-08-04T12:38:03","date_gmt":"2020-08-04T12:38:03","guid":{"rendered":"https:\/\/medxelerator.com\/?p=1390"},"modified":"2020-08-04T12:38:17","modified_gmt":"2020-08-04T12:38:17","slug":"caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment","status":"publish","type":"post","link":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/","title":{"rendered":"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment"},"content":{"rendered":"\n

Investment to fuel clinical trial towards regulatory clearance of novel cancer treatment platform<\/em><\/p>\n\n\n\n

\"\"<\/figure><\/div>\n\n\n\n

OR YEHUDA, Israel \u2013 August 4, 2020 — MEDX Xelerator<\/a>, an Israel-based medical device and digital health incubator, today announced that original portfolio company CAPS Medical<\/a>, developer of a highly selective and minimally invasive non-thermal plasma device for cancer treatment, has completed a $3.5 million Series A funding round. The round will help finance the first clinical trial of CAPS Medical\u2019s minimally invasive and selective non-thermal atmospheric plasma cancer treatment, applicable to a wide range of solid tumors types.<\/p>\n\n\n\n

\u201cCAPS was one of the first companies to join the incubator. CAPS CEO Ilan Uchitel has led his team, with the support of the incubator and its partners, to achieve all of its milestones, far ahead of schedule,\u201d said Shai Policker, CEO of MEDX Xelerator and a CAPS Medical board member. \u201cThis has resulted in CAPS successfully raising its Series A in the midst of this particularly challenging time of a global pandemic. CAPS is a perfect example of a company that aligned with the incubator\u2019s strengths: a bio-convergent approach to solving a complex unmet clinical need by integrating ideas from more than one scientific discipline.\u201d<\/p>\n\n\n\n

CAPS Medical\u2019s technology was originally developed as a collaboration between Haifa\u2019s Rambam Medical Center and The Technion – Israel Institute of Technology\u2019s Plasma Lab. The technology was brought to MEDX Xelerator for its expertise in solving complex clinical challenges with innovative technological approaches, as well as its extensive and well-connected partner network.<\/p>\n\n\n\n

Ilan Uchitel, CEO of CAPS Medical, added, \u201cI\u2019m delighted to receive this show of support for our solution during these uncertain times. Our treatment is designed to provide cancer patients with an alternative to the harsh effects of chemotherapy, enabling the application of selective non-thermal plasma treatment to solid tumors through existing minimally invasive keyhole surgical tools.\u201d<\/p>\n\n\n\n

The financing round was led by Chasing Value Asset Management<\/a> and the Los Angeles-based Israel Investment Fund Group (IIFG)<\/a>. Other participants include XACT Robotics <\/a> as well as the Technion Research and Development Foundation<\/a>.<\/p>\n\n\n\n

MEDX Xelerator continues to build its portfolio, adding new companies that are using multi-disciplinary approaches to solve complex unmet clinical challenges. <\/p>\n\n\n\n

###<\/p>\n\n\n\n

About MEDX Xelerator<\/strong><\/strong><\/p>\n\n\n\n

MEDX Xelerator is a leading MedTech incubator formed as an initiative of MEDX Ventures Group together with Boston Scientific, Intellectual Ventures\u2019 Invention Science Fund and Sheba Medical Center. Operating under the auspices of the Israel Innovation Authority, MEDX leverages the healthcare expertise and industry experience of its team with the industry leading insights of its partners to nurture its portfolio companies into successful medical ventures for the benefit of patients and health care professionals. MEDX\u2019s current portfolio companies includes: EndoWays<\/a>, Append Medical<\/a>, Exero<\/a> Medical<\/a>, CAPS Medical<\/a> and PatenSee. <\/strong><\/p>\n\n\n\n

For more information, visit https:\/\/medxelerator.com\/<\/a>. <\/p>\n\n\n\n

Follow MEDX on LinkedIn<\/a>.<\/p>\n\n\n\n

Media Contact
<\/strong>Nicole Grubner for MEDX Xelerator
nicole.grubner@finnpartners.com<\/a>
+1-929-222-8011<\/p>\n","protected":false},"excerpt":{"rendered":"

Investment to fuel clinical trial towards regulatory clearance of novel cancer treatment platform OR YEHUDA, Israel \u2013 August 4, 2020 — MEDX Xelerator, an Israel-based medical device and digital health incubator, today announced that original portfolio company CAPS Medical, developer of a highly selective and minimally invasive non-thermal plasma device for cancer treatment, has completed […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"acf":[],"yoast_head":"\nCAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment - MEDX Xelerator<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment - MEDX Xelerator\" \/>\n<meta property=\"og:description\" content=\"Investment to fuel clinical trial towards regulatory clearance of novel cancer treatment platform OR YEHUDA, Israel \u2013 August 4, 2020 — MEDX Xelerator, an Israel-based medical device and digital health incubator, today announced that original portfolio company CAPS Medical, developer of a highly selective and minimally invasive non-thermal plasma device for cancer treatment, has completed […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"MEDX Xelerator\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-04T12:38:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-04T12:38:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo-1024x425.jpg\" \/>\n<meta name=\"author\" content=\"Soli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Soli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/\"},\"author\":{\"name\":\"Soli\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de\"},\"headline\":\"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment\",\"datePublished\":\"2020-08-04T12:38:03+00:00\",\"dateModified\":\"2020-08-04T12:38:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/\"},\"wordCount\":504,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medxelerator.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo-1024x425.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/\",\"url\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/\",\"name\":\"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment - MEDX Xelerator\",\"isPartOf\":{\"@id\":\"https:\/\/medxelerator.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo-1024x425.jpg\",\"datePublished\":\"2020-08-04T12:38:03+00:00\",\"dateModified\":\"2020-08-04T12:38:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#primaryimage\",\"url\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo.jpg\",\"contentUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo.jpg\",\"width\":2161,\"height\":896},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medxelerator.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medxelerator.com\/#website\",\"url\":\"https:\/\/medxelerator.com\/\",\"name\":\"MEDX Xelerator\",\"description\":\"Accelerating Science for Life\",\"publisher\":{\"@id\":\"https:\/\/medxelerator.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medxelerator.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medxelerator.com\/#organization\",\"name\":\"MEDX XELERATOR\",\"url\":\"https:\/\/medxelerator.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png\",\"contentUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png\",\"width\":819,\"height\":333,\"caption\":\"MEDX XELERATOR\"},\"image\":{\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de\",\"name\":\"Soli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g\",\"caption\":\"Soli\"},\"url\":\"https:\/\/medxelerator.com\/author\/soli-dmedxelerator-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment - MEDX Xelerator","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/","og_locale":"en_US","og_type":"article","og_title":"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment - MEDX Xelerator","og_description":"Investment to fuel clinical trial towards regulatory clearance of novel cancer treatment platform OR YEHUDA, Israel \u2013 August 4, 2020 — MEDX Xelerator, an Israel-based medical device and digital health incubator, today announced that original portfolio company CAPS Medical, developer of a highly selective and minimally invasive non-thermal plasma device for cancer treatment, has completed […]","og_url":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/","og_site_name":"MEDX Xelerator","article_published_time":"2020-08-04T12:38:03+00:00","article_modified_time":"2020-08-04T12:38:17+00:00","og_image":[{"url":"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo-1024x425.jpg"}],"author":"Soli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Soli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#article","isPartOf":{"@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/"},"author":{"name":"Soli","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de"},"headline":"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment","datePublished":"2020-08-04T12:38:03+00:00","dateModified":"2020-08-04T12:38:17+00:00","mainEntityOfPage":{"@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/"},"wordCount":504,"commentCount":0,"publisher":{"@id":"https:\/\/medxelerator.com\/#organization"},"image":{"@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo-1024x425.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/","url":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/","name":"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment - MEDX Xelerator","isPartOf":{"@id":"https:\/\/medxelerator.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#primaryimage"},"image":{"@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo-1024x425.jpg","datePublished":"2020-08-04T12:38:03+00:00","dateModified":"2020-08-04T12:38:17+00:00","breadcrumb":{"@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#primaryimage","url":"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo.jpg","contentUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2020\/08\/CAPS-logo.jpg","width":2161,"height":896},{"@type":"BreadcrumbList","@id":"https:\/\/medxelerator.com\/caps-medical-medx-xelerators-portfolio-company-raises-3-5-million-series-a-to-advance-development-of-non-thermal-atmospheric-plasma-cancer-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medxelerator.com\/"},{"@type":"ListItem","position":2,"name":"CAPS Medical, MEDX Xelerator\u2019s Portfolio Company, Raises $3.5 Million Series A to Advance Development of Non-Thermal Atmospheric Plasma Cancer Treatment"}]},{"@type":"WebSite","@id":"https:\/\/medxelerator.com\/#website","url":"https:\/\/medxelerator.com\/","name":"MEDX Xelerator","description":"Accelerating Science for Life","publisher":{"@id":"https:\/\/medxelerator.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medxelerator.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medxelerator.com\/#organization","name":"MEDX XELERATOR","url":"https:\/\/medxelerator.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/","url":"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png","contentUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png","width":819,"height":333,"caption":"MEDX XELERATOR"},"image":{"@id":"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de","name":"Soli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g","caption":"Soli"},"url":"https:\/\/medxelerator.com\/author\/soli-dmedxelerator-com\/"}]}},"_links":{"self":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/1390"}],"collection":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/comments?post=1390"}],"version-history":[{"count":2,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/1390\/revisions"}],"predecessor-version":[{"id":1393,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/1390\/revisions\/1393"}],"wp:attachment":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/media?parent=1390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/categories?post=1390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/tags?post=1390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}